"seeking Justice" Live Radio Talk

Dr. Cameron Wolfe, M.D., Associate Professor of Infectious Diseases, Duke University Medical Center discussed details within the national active research currently being conducted with hospitalized adults battling the COVID-19 Coronavirus. His answers revealed surprising details, both positive and realistic about the intravenous drug, Remdesivir. Distinguishing the difference between this treatment and hydroxychloroquine and chloroquine drugs, he stated that the chloroquine drugs were used for the mitigation {relief} of symptoms only and the results were yet unknown. Dr. Wolfe clarified that Remdesivir targeted the DNA/ RNA molecular structure - seeking to prevent the virus from replicating inside the body. The ultimate goal is to find the correct treatment(s) and dosage(s) to serve as an antiviral. He described all parameters of this active research trial - happening in hospitals throughout the nation - stating that the research is adaptive to the results occurring in patients being tested. Further clarifyin